What’s New in MPN Research: Breakthroughs and Clinical Trials You Should Know About
Join the HealthTree Foundation for this special webinar with Dr. Prithviraj Bose where we will be learning about clinical trials for MPN patients. This is a wonderful opportunity to learn from and ask questions to a leading expert in the field.
Dalton introduces the agenda of the event and our featured speaker Dr. Prithviraj Bose
Dr. Bose talks about clinical trials and research for MPNs
Type your questions in the chat and we will answer them!
Dalton Bean
Dalton joined HealthTree in 2024 as the MPNs and MDS Program Manager. He is passionate about helping patients gain a better understanding of their health and treatment and sees it as a way to help empower individuals and their families who are affected by these diseases. Prior to joining HealthTree Dalton earned a Master’s Degree in Oncological Sciences while studying various different blood cancers. When not interacting with patients he is an avid snowboarder and hiker.
Prithviraj Bose, M.D.
Dr. Prithviraj Bose is a hematologist-oncologist and Associate Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center, where he focuses on myeloproliferative neoplasms (MPNs) and chronic lymphocytic leukemia. Dr. Bose leads clinical trials in myelofibrosis, essential thrombocythemia, and systemic mastocytosis. He serves on the NCCN MPN panel and has published extensively in The New England Journal of Medicine, Blood, and Cancer Cell.